![](/img/cover-not-exists.png)
Modeled Survival Gains of Patients with Cystic Fibrosis (CF) Aged ≥12 Years Homozygous for the F508dEL Mutation Treated with the CF Transmembrane Conductance Regulator Modulator (CFTRM) Tezacaftor/Ivacaftor (TEZ/IVA)
Lopez, A, Suthoff, E, Chandler, C, Liou, T, Konstan, M, Pelligra, C, Ward, A, Rubin, J, McGarry, LVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.1392
Date:
May, 2018
File:
PDF, 77 KB
english, 2018